News & Articles

Platform to complement Rentschler’s cell line development offering for difficult-to-express proteins

A qualitative test for the detection of nucleic acid from SARS-CoV-2

Onxeo to present new preclinical data at AACR 2020 illustrating the ability of AsiDNA™

Study suggests that type I IFN deficiency in the blood could help define a high-risk population

The COVID-19 vaccine trial is part of a global development program that will uncover the safety and immunogenicity of four mRNA vaccine candidates.

Assay will help guide treatment decisions in cases of non-small cell lung cancer

A portable and non-invasive, fingerprint-based method, ideal for on-site testing in care homes and the workplace

Leading HPLC analyzer manufacturer Tosoh Europe partners with EKF for Quo-Test HbA1c point-of-care analyzer

Mass production comes as part of a nationwide effort to support the NHS in the fight against COVID-19

The U.S. Food and Drug Administration has authorized the first coronavirus test using at-home collection of saliva samples

Partnership to broaden the availability of COVID-19 antibody testing with 100% specificity

A research team at the University of Cambridge has designed a ventilator for treating COVID-19 patients that can be quickly and cheaply manufactured

Thermo Fisher Scientific will provide 50 Ion Torrent Genexus Systems for consortia members to support global COVID-19 research

The randomized, double-blind, placebo-controlled study aims to enroll up to 40 patients with moderate-to-severe COVID-19 pneumonia in the U.S

Clinical laboratories certified to perform high complexity tests under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this ELISA

Register today to reserve a place at the Summit - it opens at 13:00 (BST) / 14:00 (CEST) / 08:00 (EDT) / 05:00 (PDT) on Monday, May 11

AMSBIO's new service utilizes their novel lentiviral system to aid the development of therapeutic drugs and vaccines

The U.S. Food and Drug Administration has approved Tabrecta (capmatinib) to treat adult patients with non-small cell lung cancer

Preliminary results from a government-sponsored study suggest that drug used to treat Ebola may help COVID-19 patients

The blood-based immunoassay test enables clinicians to identify the virus linked with COVID-19